GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Debt-to-Asset

Nortem Biogroup (XPAR:MLBIO) Debt-to-Asset : 0.47 (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Debt-to-Asset?

Nortem Biogroup's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €2.98 Mil. Nortem Biogroup's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €3.39 Mil. Nortem Biogroup's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2022 was €13.47 Mil. Nortem Biogroup's debt to asset for the quarter that ended in Dec. 2022 was 0.47.

Nortem Biogroup Debt-to-Asset Historical Data

The historical data trend for Nortem Biogroup's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Debt-to-Asset Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Debt-to-Asset
0.41 0.47

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Debt-to-Asset 0.41 0.47

Competitive Comparison of Nortem Biogroup's Debt-to-Asset

For the Packaged Foods subindustry, Nortem Biogroup's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Debt-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Debt-to-Asset falls into.


Nortem Biogroup Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Nortem Biogroup's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.976 + 3.385) / 13.468
=0.47

Nortem Biogroup's Debt-to-Asset for the quarter that ended in Dec. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.976 + 3.385) / 13.468
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nortem Biogroup  (XPAR:MLBIO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Nortem Biogroup Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Debt-to-Asset
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines